Affymetrix Inc (AFFX)

14.01
0.02 0.14
NASDAQ : Technology
Prev Close 13.99
Open 14.03
Day Low/High 14.00 / 14.05
52 Wk Low/High 8.28 / 16.15
Volume 5.03M
Avg Volume 3.49M
Exchange NASDAQ
Shares Outstanding 80.54M
Market Cap 1.13B
EPS 0.13
P/E Ratio 107.61
Div & Yield N.A. (N.A)

Friday's Health Winners & Losers

Intuitive Surgical surges on a rise in earnings.

Thursday's Health Winners & Losers

Affymetrix and Illumina settle a patent-infringement suit.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

BioMarin continues climbing on an FDA approval.

Friday's Analysts' Upgrades and Downgrades

Who made what calls.

Tuesday's Winners and Losers: Apple

The tech company's shares climb on strong sales of the iPhone in Europe.

Tuesday's Health Winners & Losers

Tuesday's Health Winners & Losers

Tutogen climbs on a merger deal with Regeneration Technologies.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

Pozen climbs on a reworked venture with AstraZeneca.

Tuesday's Health Winners & Losers

Tuesday's Health Winners & Losers

Nuerochem falls on cash-reserve estimates.

Thursday's Health Winners & Losers

Immucor climbs on an earnings beat.

Thursday's Health Winners & Losers

Thursday's Health Winners & Losers

AtheroGenics was up and Affymetrix was down in an uneven market for health care stocks.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Affymetrix is climbing.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

SuperGen is rising.

Thursday's Health Winners & Losers

Thursday's Health Winners & Losers

Luminex is higher.

Monday's Health Winners & Losers

Monday's Health Winners & Losers

Dynavax drops.

Affymetrix Revenue Gain

Shares rise more than 12%.

Giving Thanks to Biotech

Investors in Sirna, Illumina and Celgene can count their blessings this Thanksgiving.

Holiday Patterns

Momentum may wane a bit, but the days surrounding Thanksgiving may return us to the upside.

Thursday's Analysts' Upgrades and Downgrades

Thursday's Analysts' Upgrades and Downgrades

Who made what calls.

Thursday's Early Winners & Losers

Thursday's Early Winners & Losers

Affymetrix climbs after beating Street estimates, despite a third-quarter loss.

Affymetrix Better Than Expected

Affymetrix Better Than Expected

Revenue tops estimates, and the stock rises 10%.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

Icon rises, while Celgene falls.

Tuesday's Early Winners & Losers

Tuesday's Early Winners & Losers

PeopleSupport and Altiris post stronger-than-expected second-quarter results.

Affymetrix Swings to a Loss

Rising costs hamstring the genomics company in the second quarter.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Tercica climbs, but Affymetrix declines.

Solexa Builds a Better Gene Trap

Its efficient genome-sequencing technology will put the company on the map.

Today's Health Winners and Losers

Affymetrix is burned after its first-quarter results miss both its own and Wall Street's targets.

Today's Health Winners and Losers

Today's Health Winners and Losers

Discovery Labs drops after the FDA issues more requirements for the approval of its Surfaxin drug.

Heavy Option Action

These retailers are seeing a lot of activity today.

Today's Implied Volatility Leaders

Google's I.V. hit 26%, and Neurocrine Biosciences and Affymetrix spiked as well.

Today's Early Winners and Losers

Packateer and Dolby Labs soar after better-than-expected earnings reports.